Propofol + Remifentanil
Propofol + Remifentanil is a pharmaceutical drug with 6 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 3 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
0
Mid Stage
2
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
75.0%
3 of 4 finished
25.0%
1 ended early
1
trials recruiting
6
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Exploration of Appropriate BIS Range and Propofol Effect-site Concentration During Total Intravenous Anesthesia With Concomitant Adjuvants.
Anesthesia Techniques, Neuroprotection and Surgical Field in FESS Under Controlled Hypotension
Intravenous Anesthesia Versus Anesthesia With Volatile Agents in Elective Craniotomy for Tumors
Remifentanil and Laryngeal Reflex Responses in Pediatric Patients With URI
Different Hemostasis According to the Anesthetic Agents
Clinical Trials (6)
Exploration of Appropriate BIS Range and Propofol Effect-site Concentration During Total Intravenous Anesthesia With Concomitant Adjuvants.
Anesthesia Techniques, Neuroprotection and Surgical Field in FESS Under Controlled Hypotension
Intravenous Anesthesia Versus Anesthesia With Volatile Agents in Elective Craniotomy for Tumors
Remifentanil and Laryngeal Reflex Responses in Pediatric Patients With URI
Different Hemostasis According to the Anesthetic Agents
Detection of Consciousness by EEG and Auditory Evoked Potentials
All 6 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 6